[The Herald] Over 20 percent of Africans taking Efavirenz, a first line anti-retroviral drug used in the management of HIV and aids could be taking an overdose, a local scientist Professor Collen Masimirembwa has revealed. In an interview on his latest scientific development aimed at assessing the safety and effectiveness of medicines in African populations, Prof Masimirembwa, who is the president and chief scientific officer with the African Institute of Biomedical Science and Technology (AiBST), said research had sho ......
↧